Next-generation sequencing (NGS) techniques enable sequencing ... we provide Perl scripts that can process data from all major platforms (Roche 454, Illumina Genome Analyzer and ABI SOLiD).

NIH grantees have launched the database of the oral microbiome containing approximately 600 distinct microorganisms currently known to live in the mouth. A $2.3 million NHGRI grant will enable ...

Additionally, catch up on recent company news and funding outcomes. This presentation provided an insight into Roche’s (Basel, Switzerland) novel next-generation sequencing technology, sequencing by ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

short sequencing time and reasonable amount of throughput, desktop sequencers such as Ion Torrent PGM, and its second-generation technology competitors, Illumina's MiSeq® and 454 GS Junior ...

Further, the US with USD 41.8 billion market in 2023, holds majority share in the global In-vitro Diagnostics market and is likely to remain the leading region growing a CAGR of 5.0% within this ...

A linkurl:paper;http://www.pnas.org/cgi/doi/10.1073/pnas.0604351103 published this week in PNAS provides a possible glimpse at the near-term future of linkurl:next ...

Roche has bolstered its R&D pipeline in oncology and neuroscience with a pair of partnerships with Orionis Biosciences and PeptiDream, parting with upfront cash of $87 million for projects in the ...

Under this co-promotional agreement, IDT will design, synthesize, and purify the fusion primers required for certain 454 Sequencing applications under this co-promotional agreement. GEI has awarded ...

with investors also concerned about Illumina’s product sales taking a hit due to U.S. research funding cuts and looming competition from Roche’s gene-sequencing device. Morningstar analyst Jul ...

Roche fails in bid to increase dose of MS drug ... said on Tuesday activist investor Keith Meister would join the gene-sequencing maker's board and former U.S. Food and Drug Administration ...